Literature DB >> 9632714

The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin.

G Yu1, F Chen, G Levesque, M Nishimura, D M Zhang, L Levesque, E Rogaeva, D Xu, Y Liang, M Duthie, P H St George-Hyslop, P E Fraser.   

Abstract

The presenilin (PS) genes associated with Alzheimer disease encode polytopic transmembrane proteins which undergo physiologic endoproteolytic cleavage to generate stable NH2- and COOH-terminal fragments (NTF or CTF) which co-localize in intracellular membranes, but are tightly regulated in their stoichiometry and abundance. We have used linear glycerol velocity and discontinuous sucrose gradient analysis to investigate the distribution and native conformation of PS1 and PS2 during this regulated processing in cultured cells and in brain. The PS1 NTF and CTF co-localize in the endoplasmic reticulum (ER) and in the Golgi apparatus, where they are components of a approximately 250-kDa complex. This complex also contains beta-catenin but not beta-amyloid precursor protein (APP). In contrast, the PS1 holoprotein precursor is predominantly localized to the rough ER and smooth ER, where it is a component of a approximately 180-kDa native complex. PS2 forms similar but independent complexes. Restricted incorporation of the presenilin NTF and CTF along with a potentially functional ligand (beta-catenin) into a multimeric complex in the ER and Golgi apparatus may provide an explanation for the regulated accumulation of the NTF and CTF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632714     DOI: 10.1074/jbc.273.26.16470

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

Review 1.  Function and dysfunction of the presenilins.

Authors:  S S Sisodia; S H Kim; G Thinakaran
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  Membrane-anchored plakoglobins have multiple mechanisms of action in Wnt signaling.

Authors:  M W Klymkowsky; B O Williams; G D Barish; H E Varmus; Y E Vourgourakis
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

Review 3.  Presenilins: structural aspects and posttranslational events.

Authors:  F Checler
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

4.  S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease.

Authors:  W H Yu; P E Fraser
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

Review 5.  Metabolism of presenilins.

Authors:  G Thinakaran
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

6.  Activity-dependent isolation of the presenilin- gamma -secretase complex reveals nicastrin and a gamma substrate.

Authors:  William P Esler; W Taylor Kimberly; Beth L Ostaszewski; Wenjuan Ye; Thekla S Diehl; Dennis J Selkoe; Michael S Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

7.  Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.

Authors:  D M Mann; S M Pickering-Brown; A Takeuchi; T Iwatsubo
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

8.  Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation.

Authors:  Dieter Edbauer; Edith Winkler; Christian Haass; Harald Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

9.  Three-amino acid spacing of presenilin endoproteolysis suggests a general stepwise cleavage of gamma-secretase-mediated intramembrane proteolysis.

Authors:  Akio Fukumori; Regina Fluhrer; Harald Steiner; Christian Haass
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

10.  Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis.

Authors:  J Walter; A Schindzielorz; J Grünberg; C Haass
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.